SPG vs TCRX · rev $3.55B vs rev $2.0M
SPG (SPG) versus Tscan Therapeutics Inc (TCRX) — a side-by-side from cached financials, not a winner call.
SPG (SPG) common stock.
Tscan Therapeutics Inc (TCRX) is a biotechnology company listed on NASDAQ.
Latest reported SPG revenue for 2026-06-30 was $3.55B. Net income was $1.14B. SPG currently screens at market cap $0.
Latest reported TCRX revenue for 2026-06-30 was $2.0M. Net income was -$59.0M. TCRX currently screens at market cap $62.1M.
SPG currently screens at market cap $0. TCRX currently screens at market cap $62.1M.
Not investment advice. Open the SPG and TCRX stock pages for the full models.
Not investment advice.